ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
AtriCure, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 27, 2026
$55.53−0.54 (-0.96%)
Close on Oct 19, 2026
- Market cap
- $2.71B
- P/E (TTM)
- 264.4
- Dividend yield
- –
AtriCure statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | AtriCure | Industry median |
|---|---|---|
| Market Cap | $2.82B | $230.55M |
| Enterprise Value | $2.72B | $202.97M |
| PE Ratio | 264.43 | 31.60 |
| PS Ratio | 4.96 | 3.10 |
| PB Ratio | 5.47 | 3.04 |
| P/TBV Ratio | 11.85 | 4.43 |
| P/FCF Ratio | 53.18 | 27.30 |
| P/OCF Ratio | 43.50 | 22.47 |
Enterprise value
| Measure | AtriCure | Industry median |
|---|---|---|
| EV / Sales | 4.77 | 2.91 |
| EV / EBITDA | 210.85 | 19.74 |
| EV / EBIT | 210.85 | 24.80 |
| EV / FCF | 51.17 | 27.89 |
Income (trailing twelve months)
| Measure | AtriCure | Industry median |
|---|---|---|
| Revenue | $569.62M | $102.39M |
| Gross Profit | $434.61M | $60.36M |
| Operating Income | $12.89M | -$4.31M |
| Pretax Income | $12.09M | -$2.37M |
| Net Income | $10.55M | -$6.57M |
| EBITDA | $12.89M | -$1.98M |
| EPS (Diluted) | $0.21 | -$0.08 |
Margins
| Measure | AtriCure | Industry median |
|---|---|---|
| Gross Margin | 76.3% | 55.2% |
| Operating Margin | 2.26% | -6.04% |
| Pretax Margin | 2.12% | -4.11% |
| Profit Margin | 1.85% | -10.5% |
| EBITDA Margin | 2.26% | -2.67% |
| FCF Margin | 9.32% | 0.02% |
Returns
| Measure | AtriCure | Industry median |
|---|---|---|
| Return on Equity (ROE) | 2.15% | -18.2% |
| Return on Assets (ROA) | 1.64% | -13.3% |
| Return on Invested Capital (ROIC) | 2.75% | -3.69% |
| Return on Capital Employed (ROCE) | 2.17% | -9.07% |
Growth
| Measure | AtriCure | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 13.9% | 8.85% |
| FCF Growth (YoY) | 110.0% | 9.68% |
| Revenue Growth (3Y CAGR) | 17.4% | 7.08% |
| Revenue Growth (5Y CAGR) | 20.9% | 11.8% |
Balance sheet
| Measure | AtriCure | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $167.79M | $36.66M |
| Total Debt | $61.00M | $97.65M |
| Net Cash (Debt) | $106.79M | $3.92M |
| Net Cash Per Share | $2.10 | $0.28 |
| Equity (Book Value) | $516.43M | $55.33M |
| Book Value Per Share | $10.15 | $2.87 |
| Tangible Book Value | $238.39M | $10.79M |
| Working Capital | $263.62M | $56.72M |
Financial position
| Measure | AtriCure | Industry median |
|---|---|---|
| Current Ratio | 4.22 | 2.48 |
| Quick Ratio | 3.02 | 1.53 |
| Debt / Equity | 0.12 | 0.41 |
| Debt / EBITDA | 4.73 | 2.40 |
| Debt / FCF | 1.15 | 3.49 |
| Net Debt / EBITDA | -8.28 | 1.53 |
| Interest Coverage | 2.29 | -1.85 |
Cash flow (trailing twelve months)
| Measure | AtriCure | Industry median |
|---|---|---|
| Operating Cash Flow | $64.94M | -$566.22K |
| Capital Expenditures | -$11.83M | -$3.69M |
| Free Cash Flow | $53.11M | -$696.00K |
| FCF Per Share | $1.04 | -$0.02 |
Efficiency
| Measure | AtriCure | Industry median |
|---|---|---|
| Asset Turnover | 0.89 | 0.58 |
| Inventory Turnover | 1.68 | 2.21 |
| Revenue Per Employee | $421.94K | $322.92K |
| Profits Per Employee | $7.82K | -$51.88K |
| Employee Count | 1,350 | 185 |
Dividends and yields
| Measure | AtriCure | Industry median |
|---|---|---|
| Earnings Yield | 0.37% | -6.88% |
| FCF Yield | 1.88% | -0.45% |
Shares
| Measure | AtriCure | Industry median |
|---|---|---|
| Shares Outstanding | 50,866,300 | 44,302,700 |
| Shares Change (YoY) | 2.35% | 3.36% |
| Shares Change (QoQ) | 0.45% | 0.27% |
| Float | 48,811,400 | 37,462,700 |
| Shares Held by Insiders | 4.04% | 10.5% |
| Shares Held by Institutions | 103.9% | 63.5% |
Taxes
| Measure | AtriCure | Industry median |
|---|---|---|
| Income Tax | $1.54M | $1.52M |
| Effective Tax Rate | 12.8% | 18.5% |
Scores
| Measure | AtriCure | Industry median |
|---|---|---|
| Graham Number | $6.93 | $35.97 |
| Graham Upside | -87.5% | -57.0% |
| Altman Z-Score | 11.11 | 1.95 |
| Piotroski F-Score | 7 | 5 |
Calculated by StockData from AtriCure's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.